Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-09

Clinical Trial Update: Efficacy and Toxicity of SCART [NA]

View source ↗

Summary

A clinical trial evaluating SCART for tumors at least 5 cm in size has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCART

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Tumor Size Greater Than or Equal to 5 cm | NA | Status: WITHDRAWN